IndraLab
Statements
reach
"To understand the molecular mechanisms by which this oncoprotein alters transforming phenotypes, and since our previous work indicated that SHP-2 protein tyrosine phosphatase activity modulated EGFRvIII activation and downstream signaling, we examined whether SHP-2 plays a role in EGFRvIII induced oncogenesis by using both PTEN deficient U87MG.EGFRvIII and PTEN-intact LN229.EGFRvIII cells."